DT
Therapeutic Areas
Terran Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| TerXT | Schizophrenia | Late-stage (Pre-Phase 3) |
| Idazoxan XR | Schizophrenia, Alzheimer's Disease | Phase 2/3 |
| Eplivanserin / Volinanserin (Monotherapy) | Parkinson's Disease Psychosis, other neuropsychiatric illnesses | Phase 3 |
| Eplivanserin / Volinanserin (Combination) | Adjunct to Psychedelic Therapy (e.g., for tailoring/aborting effects) | Pre-clinical/Phase 1 |
| Psychedelic & Empathogen Portfolio (e.g., psilocybin, MDMA prodrugs, psychoplastogens) | Various Neuropsychiatric Disorders | Pre-clinical |